AzTrials
AzTrials

Feeding Tube ComplicationNCT04621734

Retention of Nasoenteric Feeding Tubes in Pediatric Patients Using a Nasal Bridle

A study testing AMT BridlePro Device and Adhesive Tape in people with Feeding Tube Complication, run by The University of Texas Health Science Center at San Antonio at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A study to compare tube dislodgment rates when a nasoenteric feeding tube is secured with adhesive tape vs the AMT BridlePro device. Read more about this study

Who is it for?
Ages Up to 18 years
Conditions the study is for
Feeding Tube Complication
What is being tested?
AMT BridlePro Device and Adhesive Tape
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
35 participants
Where
1 siteUnited States
Study dates
18 Feb 2020to 16 Sep 2021
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Need for nasoenteric feeding
  • Admitted to University Hospital
  • Age 0-18 years

Who cannot join

  • Facial trauma
  • Nasal airway obstructions
  • Thrombocytopenia (<100 K/μL)
  • s/p septoplasty
  • Patients with vomer bone graft
  • Nasoenteric feeding tube placed and secured prior to being screened for study
  • Contraindication for the use of the BridlePro
  • Does not meet inclusion criteria

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University Health System

    San Antonio, Texas, 78229

Other trials in United States

About this study

Official title: Improving Retention of Nasoenteric Feeding Tubes in Pediatric Patients Using a Nasal Bridle

A study to compare tube dislodgment rates when a nasoenteric feeding tube is secured with adhesive tape vs the AMT BridlePro device.

Read the detailed description

The adhesive tape will be the tape available in the unit and will be placed by the nurse or provider at the time of nasoenteric tube placement. The tape will be placed around the tube and secured to the cheek on the side of tube. The tape will be replaced as needed per nursing discretion when soiled or the adhesive properties are failing and this information will be tracked. The AMT BridlePro will be placed by the nurse or provider at the time of nasoenteric tube placement. Placement will use the BridlePro system included in the individual BridlePro packaging. Placement and securement will follow manufacturer recommendations and teaching. The BridlePro encircles the vomer bone of the nasal cavity to secure the tube. Sedation medication may be given per standard of care for nasoenteric tube placement at the discretion of the provider team but no separate or additional sedation medication will be given for securement with adhesive tape or the BridlePro.

Being tested
AMT BridlePro Device, Adhesive Tape

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AMT BridlePro DeviceDevice

    Also called Applied Medical Technology (AMT) BridlePro Device

    A device used as an alternative securement method using the structure of the nasal cavity to secure the nasoenteric tube.

  • Adhesive TapeDevice

    Also called Tape

    Adhesive tape used to secure nasoenteric tube

Study groups in NCT04621734
Study groupRoleWhat they receive
Nasal bridle to secure feeding tubeActive comparatorThe nasal bridle will be used to secure the nasoenteric feeding tube.
Receives: Device: AMT BridlePro Device
Adhesive Tape use to secure feeding tubePlacebo comparatorAdhesive tape will be used as standard of care to secure the nasoenteric feeding tube.
Receives: Device: Adhesive Tape

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Tube Dislodgements Per 10 Tube Days.

    The number of times the tube is dislodged for every 10 days of feeding tubes.

    Measured: 10 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Nov 2020
  2. Study start18 Feb 2020
  3. Primary completion30 Apr 2021
  4. Study completion16 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
35 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04621734
Sponsor's protocol ID
HSC20190225H
Status last verified
Aug 2023
First submitted
3 Nov 2020
Last updated
14 Aug 2023
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Publications

  • Foster M, Armijo-Garcia V, Gelfond J, Meyer AD. Improving retention of pediatric feeding tubes with a nasal bridle: a randomized controlled trial. Trials. 2025 May 14;26(1):159. doi: 10.1186/s13063-025-08867-x.

    PubMed 40369642

Questions about this trial

What is this clinical trial studying?

A study testing AMT BridlePro Device and Adhesive Tape in people with Feeding Tube Complication, run by The University of Texas Health Science Center at San Antonio at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 14 Aug 2023). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Tube Dislodgements Per 10 Tube Days. (time frame: 10 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04621734, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in